Stocks

JPMorgan Raises LifeStance Health Price Target to $13.00

Guavy AI Editorial Team Published August 14, 2026

Instruments

JPM

LifeStance Health Group (NASDAQ:LFST) has had its price target boosted by JPMorgan Chase & Co. from $9.00 to $13.00 in a research note issued on Friday, according to MarketBeat.

The brokerage currently has a 'neutral' rating on the stock and suggests a potential upside of 2.48% from the company's previous close.

This is not the only recent price target adjustment for LifeStance Health Group - several other analysts have also increased their targets.

The Wire

Keep reading for free.

You've read 3 free articles in the last 24 hours. Create a free account for unlimited access, no card required.

Create free account Already have an account? Sign in

No spam. Unsubscribe anytime.